Document |
Document Title |
WO/2013/055983A1 |
Novel semi-crystalline, epsilon-caprolactone-rich block copolymers of epsilon-caprolactone and p-dioxanone for long term absorbable medical applications are disclosed. The novel polymer compositions are useful for long term absorbable su...
|
WO/2013/053483A1 |
The subject matter of the present application are methods for producing a plastic containing complexes of at least one nucleic acid and at least one organic cation.
|
WO/2013/035969A1 |
The present invention relates to a high strength tool for fixing soft tissue, comprising: a sleeve which is formed in the shape of a pipe in which both ends thereof are open and has an incision in which the outer surface thereof is incis...
|
WO/2013/034641A1 |
The invention concerns a medical device comprising at least one device body and a flock material, methods for manufacturing the medical device and a surgical combination comprising along the medical device a delivery instrument.
|
WO/2013/034644A1 |
The invention concerns a surgical suture comprising a suture body and a flock material, methods for manufacturing the surgical suture and a surgical combination comprising along the surgical suture at least one surgical needle.
|
WO/2013/027189A1 |
The invention concerns a suture coated with albumin (an albumin-coated suture) for use in introducing cells seeded thereon into a soft tissue of a patient. The suture of the invention advantageously comprises cells seeded thereon. The su...
|
WO/2013/000227A1 |
A method for synthesizing a medical grade biodegradable material, poly(lactic-co-glycolic acid), by biomass creatinine-catalyzed copolycondensation of lactic acid and glycolic acid. The present invention uses an in vivo arginine metaboli...
|
WO/2012/112793A9 |
A suture assembly comprising: a first suture having a generally 0- shaped configuration comprising a first arm, a second arm, a first bridge connecting the first arm to the second arm, and a second bridge connecting the first arm to the ...
|
WO/2012/156805A1 |
The present invention relates to threads, fibres or filaments, as well as to a textile item and a medical device obtained from said threads for improving the healing of the skin, in particular by activating collagen synthesis on the surf...
|
WO/2012/151366A2 |
Devices, tools, systems, kits and methods for closing a tissue opening non-invasively are presented. The devices include a tissue closure device that reliably induces eversion of tissue edges that define a tissue opening. The devices may...
|
WO/2012/129534A2 |
A suture having a first end for penetrating tissue, an elongated suture body having a periphery; a plurality of retainers on the periphery, and a second end having a variable loop of variable circumference, wherein the variable loop incl...
|
WO/2012/128432A1 |
The present invention relates to a medical suture having micro cogs on a surface thereof, and a method for manufacturing same. The method for manufacturing the medical suture with the micro cogs on the surface thereof includes: a step of...
|
WO/2012/124562A1 |
The present invention is characterized by providing a bioresorbable suture thread having high flexibility, high tensile strength, knot strength, a shape that is maintained without a plurality of threads unraveling even at cut ends or tor...
|
WO/2012/121439A1 |
The present invention relates to an open / close-capable clip having the ability to stop the bleeding which occurs during surgery, and an open / close-capable clip manipulating tool using the same. The open / close-capable clip comprises...
|
WO/2012/121986A2 |
The disclosure describes implantable bioprosthesis and constructs having an implantable woven ribbon with at least one integrated suture.
|
WO/2012/121538A2 |
The present invention provides a suture thread for safely stitching without having to tie a portion of all of the knots which are required when suturing. More specifically, the present invention provides the suture thread comprising a su...
|
WO/2012/111309A1 |
[Problem] To provide: a process for producing a double-raschel-knitted tube for artificial blood vessels, in which the occurrence of thread breakage or fluffing can be minimized and which can be knitted with high efficiency; and a double...
|
WO/2012/107345A1 |
The present invention relates to implants for use in surgical and operative procedures, wherein the implant consists of alloplastic material and is coated with blood plasma or with one or more constituents of blood plasma. The invention ...
|
WO/2012/106127A2 |
A textile yarn includes a first segment and a second segment. The first segment includes a plurality of first strands and has a substantially constant first denier. The second segment includes a plurality of second strands integrated tog...
|
WO/2012/088232A2 |
A medical device for installing sutures to close an incision in tissue or human skin is disclosed. The suturing device may provide first and second arcuate needles. Once properly positioned, the first and second arcuate needles are drive...
|
WO/2012/073212A2 |
|
WO/2012/074141A1 |
The present invention relates to a blood vessel anastomosis device, and more particularly, to a blood vessel anastomosis device that uses a suture to automatically perform a blood vessel anastomosis operation. An automatic blood vessel a...
|
WO/2012/069559A1 |
The invention relates to a method for producing a nanofiber-based product, comprising the steps of providing a carrier material solution comprising a carrier material, and of bringing the carrier material in contact with a collector by e...
|
WO/2012/064902A2 |
A removable self-retaining suture system and methods for use thereof in emergency situations. The system comprises one or more self-retaining suture segments and a grasp engagement element. The system may be used for temporary wound clos...
|
WO/2012/060623A2 |
The present invention relates to a cyanoacrylate-based bio-adhesive composition, and aims to provide a cyanoacrylate-based bio-adhesive composition having an excellent biodegradability and anti-bacterial effect. The present invention pro...
|
WO/2012/061658A2 |
A drug-eluting self-retaining suture comprises a filament, a plurality of retainers, and a drug impregnated in or coated on the filament. The shape and distribution of retainers modifies the in vivo release kinetics of the drug. The drug...
|
WO/2012/054301A1 |
This disclosure relates generally to soft tissue augmentation threads, methods of making such threads and uses thereof, for example, in aesthetic applications (e.g., facial contouring, soft tissue augmentation products), surgery (e.g., s...
|
WO/2012/047815A2 |
A closure device having evertable arms for capturing and everting tissue and method for its use with an invasive scope, such as an endoscope, for full-thickness closure of perforations and leaks in the walls of an intraluminal bodily space.
|
WO/2012/039367A1 |
A suture reinforcing material which is for use in automatic suturing devices and which exhibits excellent reinforcing effect is provided. A suture reinforcing material for use in automatic suturing devices which includes a sheet (A) that...
|
WO/2012/036800A2 |
Embodiments of the disclosed technology provide systems, devices, and methods of creating an electrosurgical tissue seal that is augmented with a seal-enhancing composition. One embodiment of a device includes a set of opposing electrosu...
|
WO/2012/020412A2 |
The invention relates to a fibrin-based scaffold suitable for supporting a population of cells comprising mesenchymal stem cells (MSC) and/or umbilical tissue derived cells (UTC) at the site of administration for a prolonged period of ti...
|
WO/2012/012336A2 |
A wound closure system and a method of reducing the size of an open wound are disclosed. A suture line is sutured through body tissue adjacent an open wound, the suture line sutured so as to pass into the body tissue at an entry point an...
|
WO/2011/159862A2 |
A suture system that includes at least one suture having an end portion, a loop portion configured to be disposed about a fixed point and an anchor configured to be connected to the end portion for anchoring the suture to tissue adjacent...
|
WO/2011/155700A2 |
The present invention relates to a surgical suture and to a method for manufacturing a biodegradable surgical suture with a looped end, which easily provides a knotting effect, even without actual knotting, at the body part injected by a...
|
WO/2011/139916A2 |
A self-retaining suture has a suture thread less than 1 millimeter nominal diameter. A plurality of retainers is cut into the suture thread using a high accuracy retainer cutting machine. The retainer cutting machine has sufficient accur...
|
WO/2011/135082A1 |
The invention concerns a multifilament yarn construction comprising a core part and a sheath part, the core part comprising a plurality of core filaments, and the sheath part comprising a plurality of sheath filaments. Furthermore, the i...
|
WO/2011/126588A1 |
A crimpable magnesium sleeve for securing a suture within the body and for dissolving over time while introducing only compatible amounts of magnesium into the body. An instrument for placing such a sleeve on a suture crimping the sleeve...
|
WO/2011/119821A1 |
The present disclosure relates to a method of forming yarns and preparing surgical devices therefrom. The yarns include at least one first filament possessing a polymer core and first reactive members known to have click reactivity on a ...
|
WO/2011/119742A2 |
Biocompatible coatings and spin finishes that can be applied to polyhydroxyalkanoate (PHA) polymers, and medical devices made from PHA polymers, have been developed. The coatings impart good lubricity to PHA polymers, particularly to fib...
|
WO/2011/119621A2 |
A thin resilient strand (32), such as medical suture material, extends from a stiffer shank (30). The strand can form a resilient hook and/or it can have an arcuate free end to engage tissue such as the interior of a capsular bag (22) at...
|
WO/2011/119885A1 |
The present disclosure relates to a method of forming yarns and preparing surgical devices therefrom. The yarns include at least one first filament possessing a polymer core and first reactive members known to have click reactivity on a ...
|
WO/2011/095203A1 |
A fluid-swellable fiber (1) in particular for the use as a surgical suture, the fiber comprising chitosan, the fiber's (1) swelling ratio being less than 100%, and a fabric comprising the fiber. Moreover, a method of manufacturing from a...
|
WO/2011/096753A2 |
The present invention relates to an embolus-forming in-vivo indwelling coil in which the direction of action of force being applied to the embolus-forming coil changes by the curvature of the coil when the coil is in-vivo indwelled, such...
|
WO/2011/090224A1 |
The present invention relates to a method for coating a medical product with a pharmaceutical substance. A sticky gel-type pharmaceutical substance is used to facilitate the coating of a medical product. Furthermore, a gel-type pharmaceu...
|
WO/2011/088205A1 |
An antimicrobial composition comprising an ionic complex of an anionic polyester with an antimicrobial metal, wherein the anionic polyester has an ion exchange capacity from about 0.19 meq/g to about 1.0 meq/g.
|
WO/2011/058123A2 |
The invention relates to a treated HPPE yarn characterized in that the treated HPPE yarn comprises: elemental metal; the elemental metal forms a layer that adheres to the surface of the HPPE yarn and covers at least partly the surface of...
|
WO/2011/059408A1 |
The present invention relates to a biodegradable thermoplastic elastomer having the general formula A-B-A wherein each A is an amorphous polymer having a glass transition temperature (Tg) >40° C or a semi-crystalline polymer having a gl...
|
WO/2011/056530A1 |
A medical device having an antimicrobial coating. The device has a first coating layer having an antimicrobial agent over at least part of the outer surfaces of the device. The first coating has an outer surface. There is a second discon...
|
WO/2011/053562A2 |
The present invention is directed to absorbable polyether esters that have been found to reduce bacterial adhesion to materials such as medical devices and implants. More specifically, the invention is directed to novel amorphous co-poly...
|
WO/2011/053375A1 |
The present invention is directed to a device for implanting a plurality of drug depots at or near a target tissue site beneath the skin of a patient. The device comprises at least three or more drug depots, wherein each of the at least ...
|